CorNeat Vision
CorNeat Vision is dedicated to developing innovative biomimetic medical solutions aimed at addressing unmet medical needs across various therapeutic fields. Their mission is to harness biomimicry to improve health and equality worldwide, focusing on creating permanent, synthetic implants that integrate seamlessly with human tissue.
What We Do
A patented synthetic cornea that provides a long-lasting medical solution for corneal blindness, pathology, and injury. It allows corneally blind patients to rehabilitate normal vision immediately following a straightforward implantation procedure.
A non-degradable tissue-integrating ophthalmic surgical matrix designed to reinforce the sclera and aid in the physical reconstruction of the ocular surface. The CorNeat EverPatch received FDA 510(k) clearance in June 2023, marking a significant milestone for the product.
A revolutionary solution for glaucoma that regulates intraocular pressure and addresses the shortcomings of existing solutions.
The CorNeat gPatch is the first permanent & tissue-integrating periodontal surgical matrix for Guided Bone Regeneration (GBR) and gingival recession surgeries. It provides a permanent infrastructure for gingival tissue regeneration and is poised to disrupt the gingival soft tissue repair market.
Key People
News & Updates
Come and visit our booth at the American Glaucoma Society's annual meeting.
Our synthetic cornea, the CorNeat KPro, is featured in the Corneal Physician magazine!
A profile on our CEO and VP R&D, Almog Aley-Raz.
The CorNeat EverPatch, our synthetic tissue patch, hits the newsstands!
The CorNeat EverPatch received FDA 510(k) clearance in June 2023, marking a significant milestone for the product.
The CorNeat KPro successfully completed its First-in-Human trial, allowing corneally blind patients to regain their sight and independence.